Drugs / Piperacillin/Tazobactam
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04895657 | Jul 2018 → Jan 2020 | gram-negative bacterial infections | Ain Shams University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Piperacillin/Tazobactam | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04895657 ↗ |
| Route | Intravenous | “4.5 gm Piperacillin/Tazobactam I.V intermittent over 30 min. every 8 hours.” NCT04895657 ↗ |